Global Access Diagnostics reintroduces IT-Leish test for visceral leishmaniasis
Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics, has introduced IT-Leish, a rapid diagnostic test (RDT) for visceral leishmaniasis (VL). The company acquired the manufacturing rights for IT-Leish from Bio-Rad in September 2022 to prevent its withdrawal from the market and has since ensured the regulatory requirements have been met for reintroduction […]
